[Side effects of gastric muco-protective agents].
Sugimori
Satoshi
S
Department of Gastroenterology, Osaka City University Medical School.
Watanabe
Toshio
T
Arakawa
Tetsuo
T
D000277:Adjuvants, Pharmaceutic / Q000009:adverse effects; D000409:Alanine / Q000009:adverse effects / Q000031:analogs & derivatives; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives; D000535:Aluminum / Q000009:adverse effects; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D004224:Diterpenes / Q000009:adverse effects; D004347:Drug Interactions; D005744:Gastric Acid; D005746:Gastric Emptying / Q000502:physiology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D016595:Misoprostol / Q000009:adverse effects; D015363:Quinolones / Q000009:adverse effects; D013469:Sulpiride / Q000009:adverse effects; D014148:Tranexamic Acid / Q000009:adverse effects / Q000031:analogs & derivatives
D000277:Adjuvants, Pharmaceutic; D000897:Anti-Ulcer Agents; D004224:Diterpenes; D015363:Quinolones; D016595:Misoprostol; C000665:cetraxate; D014148:Tranexamic Acid; D013469:Sulpiride; D000535:Aluminum; D000527:Alprostadil; C045125:ornoprostil; C052785:rebamipide; D000409:Alanine; C031049:geranylgeranylacetone